Search by Drug Name or NDC
NDC 00245-0147-60 Pacerone 200 mg/1 Details
Pacerone 200 mg/1
Pacerone is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Upsher-Smith Laboratories, LLC. The primary component is AMIODARONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Amiodarone is used to treat and prevent certain types of serious, life-threatening ventricular arrhythmias (a certain type of abnormal heart rhythm when other medications did not help or could not be tolerated. Amiodarone is in a class of medications called antiarrhythmics. It works by relaxing overactive heart muscles.
Related Packages: 00245-0147-60Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Amiodarone
Product Information
| NDC | 00245-0147 |
|---|---|
| Product ID | 0245-0147_c6c66dbb-cc0b-4576-9248-e20255e83cf0 |
| Associated GPIs | 35400005000305 |
| GCN Sequence Number | 000266 |
| GCN Sequence Number Description | amiodarone HCl TABLET 200 MG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 10920 |
| HICL Sequence Number | 000083 |
| HICL Sequence Number Description | AMIODARONE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Pacerone |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Amiodarone Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | AMIODARONE HYDROCHLORIDE |
| Labeler Name | Upsher-Smith Laboratories, LLC |
| Pharmaceutical Class | Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075135 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00245-0147-60 (00245014760)
| NDC Package Code | 0245-0147-60 |
|---|---|
| Billing NDC | 00245014760 |
| Package | 60 TABLET in 1 BOTTLE (0245-0147-60) |
| Marketing Start Date | 2011-01-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.11264 |
| Pricing Unit | EA |
| Effective Date | 2022-03-23 |
| NDC Description | PACERONE 200 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 6 |
| Classification for Rate Setting | B |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis